NYSEAMERICAN:MTNB - Matinas BioPharma Holdings, Inc.
$0.71
 $-0.01
-1.39%
4:00PM EDT
2019-07-22
Matinas BioPharma Holdings, Inc., incorporated on May 21, 2013, is a clinical-stage biopharmaceutical company. The Company is engaged in identifying and developing therapeutics for the treatment of serious and life-threatening infections. The Company is engaged in developing a pipeline of product and development candidates, with an initial focus on serious fungal and bacterial infections. The Company's cochleate delivery technology platform is designed for the targeted delivery of pharmaceuticals directly to the site of infection or inflammation. The Company's technology utilizes lipid-crystal nano-particle cochleates to nano-encapsulate existing drugs, which is designed to make safer, more tolerable, less toxic and orally bioavailable. The Company's technology combines the use of lipids as active pharmaceutical ingredients (APIs) and the use of lipids in cochleate-shaped lipid-crystal nano-particle drug delivery vehicles. The primary chemical components of its cochleate delivery technology are soy-derived phosphatidylserine (PS) and calcium. The size of the Company's lipid-crystal cochleate particles is typically in the range of 50-500 nanometers.MAT2203The Company's anti-infective product candidate, MAT 2203, is an application of its cochleate delivery technology to a spectrum anti-fungal drug called amphotericin B. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  MTNB     avg for
industry  
  avg for
sector  
42 stocks weight:  2. 73   217. 37   399. 45  
42 stocks rank:  4. 40 K 1. 27 K 716. 99  
# analyst opinions:  4. 00   13. 21   13. 71  
mean recommendation:  1. 70   2. 10   2. 04  

quick ratio:  12. 65   5. 49   1. 88  
current ratio:  12. 81   5. 87   2. 36  

target price low:  1. 27   83. 44   114. 90  
target price avg:  0. 45   106. 20   137. 90  
target price high:  0. 50   132. 30   158. 97  
1-yr high:  1. 41   111. 86   142. 57  
last close:  0. 72   86. 79   125. 44  
50-day avg:  0. 88   86. 68   122. 63  
200-day avg:  0. 93   89. 22   121. 38  
1-yr low:  0. 35   69. 78   100. 51  
volume:  541. 15 K 2. 62 M 3. 43 M
50-day avg volume:  739. 08 K 3. 20 M 4. 16 M
200-day avg volume:  1. 46 M 2. 99 M 4. 75 M

1-day return:  -3. 39 % -1. 30 % -0. 99 %
this week return:  -16. 29 % 0. 45 % -0. 20 %
12-wk return:  -30. 77 % 0. 94 % 4. 84 %
52-wk return:  86. 33 % -1. 30 % 10. 55 %

enterprise value (EV):  77. 89 M 45. 10 B 122. 38 B
market cap:  102. 95 M 38. 96 B 108. 40 B
EBITDA:  -14. 37 M 4. 20 B 8. 19 B
enterprise multiple (EV/EBITDA):  -5. 42   5. 38   11. 93  
enterprise/revenue (EV/R):  867. 24   57. 92   10. 21  
total revenue:  89. 81 K 9. 91 B 39. 98 B
total debt:  4. 65 M 10. 90 B 17. 48 B
debt/equity:  10. 80   57. 18   120. 05  
net income (common):  -15. 05 M 2. 07 B 4. 05 B

shares outstanding:  142. 99 M 538. 09 M 1. 24 B
shares:  115. 08 M 548. 00 M 1. 22 B
shares short:  5. 34 M 10. 98 M 11. 87 M
shares short prior month:  5. 13 M 9. 32 M 12. 05 M
short ratio:  8. 30   5. 60   3. 34  
short % of float:  5. 52 % 6. 48 % 2. 64 %
total cash/share:  0. 28   10. 98   9. 19  
total cash:  39. 41 M 5. 93 B 6. 10 B
free cash flow:  -4. 56 M 2. 92 B 4. 55 B
operating cash flow:  -10. 54 M 3. 80 B 5. 78 B

book value:  0. 23   13. 35   27. 45  
price/book:  3. 09   4. 60   8. 78  
gross profits:  -6. 67 M 7. 44 B 36. 13 B
operating margins:  -16288. 19 % -308. 40 % -28. 55 %
EBITDA margins:  0. 00 % 13. 17 % 23. 38 %
profit margins:  0. 00 % 10. 44 % 14. 18 %
gross margins:  0. 00 % 35. 80 % 55. 40 %

1-yr max volatility:  0. 00 % --- ---
1-yr mean volatility:  0. 00 % 1. 66 % 1. 03 %

1-yr EPS:  -0. 14   2. 10   4. 23  
forward EPS:  -0. 16   3. 45   7. 10  
P/E:  -4. 97   1. 90   32. 10  
forward P/E:  -4. 50   6. 46   15. 47  
PE/G:  0. 36   0. 70   -0. 54  
growth:  -13. 95 % 265. 63 % 79. 11 %
earnings high:  -0. 03   0. 89   1. 68  
earnings avg:  -0. 03   0. 70   1. 57  
earnings low:  -0. 04   0. 46   1. 46  
revenue high:  90. 00 K 2. 57 B 11. 07 B
revenue avg:  20. 00 K 2. 51 B 10. 91 B
revenue low:  -0. 00   2. 45 B 10. 73 B
return on assets:  -29. 46 % -2. 34 % 5. 28 %
return on equity:  -54. 53 % -90. 08 % 133. 53 %
revenue/share:  0. 00   12. 72   60. 04  

beta (1yr vs S&P500):  0. 86   1. 27   0. 91  
sharpe (1yr):  1. 08   0. 16   0. 77  

held % insiders:  10. 40 % 6. 06 % 3. 29 %
held % institutions:  13. 41 % 78. 22 % 69. 37 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-21 : MTNB
.    100.901 =       100.901 :: --> INITIAL WEIGHT <--
.    - 0.145 =       100.756 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 2.116 =       213.187 :: P/E factor
.    x 1.295 =       275.987 :: PE/G factor
.    x 1.733 =       478.284 :: beta factor
.     x 1.08 =        516.43 :: sharpe factor
.    x 2.182 =      1127.033 :: current ratio factor
.    x 1.042 =      1174.412 :: quick ratio factor
.    x 1.059 =      1243.148 :: short ratio factor
.    x 3.142 =      3905.465 :: EV/R factor
.    x 1.033 =      4034.017 :: price-to-book factor
.    x 0.644 =      2596.474 :: debt-to-revenue factor
.     x 1.09 =      2831.116 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.121 =      6004.211 :: sector+industry 1-year gains factor
.    x 1.009 =      6060.819 :: industry 12-weeks return factor
.    x 1.308 =      7926.876 :: industry 2-weeks return factor
.    x 0.932 =      7384.299 :: "drift" penalty 3 days ago
.    x 0.978 =      7219.569 :: "drift" penalty 5 days ago
.    / 2.101 =      3436.848 :: overall "drift" factor
.    x 0.648 =      2227.458 :: largest single-day jump factor
.    x 0.061 =       135.325 :: low price factor
.     x 0.09 =        12.199 :: notable returns + performance factor
.                               --> PROJECTIONS <--
.    x 0.026 =         0.312 :: forward EPS factor
.    x 0.646 =         0.202 :: forward P/E factor
.    x 1.185 =         0.239 :: industry recommendation factor
.    x 2.442 =         0.583 :: company recommendation factor
.    x 1.003 =         0.585 :: factor historical industry gain for week 29
.   x 10.013 =         5.858 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =         1.556 :: reduced for readability
.    + 1.174 =          2.73 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                       2.73 :: FINAL WEIGHT for NYSEAMERICAN:MTNB


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org